The Global Peri-implantitis Market size was valued at USD 0.71 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 8% from 2022 to 2028.
Peri-implant disease is associated with two main entities: peri-implantitis and peri-implant mucositis. Peri-implant mucositis is an inflammatory reaction of the soft tissue surrounding the implant. Peri-implantitis is defined as an inflammatory reaction that results in loss of tissue and bone surrounding dental implants. Anaerobic plaque bacteria can adversely affect peri-implant tissue health, leading to peri-implantitis disease. Improper distribution of chewing pressure on the tissue around the implant can lead to peri-implantitis disease. Treatment of peri-implantitis is a major concern as peri-implantitis can cause infection of the surrounding tissues, loosening of the artificial support, and inflammatory processes. Peri-implantitis can result in bone loss around the implant and loss of the implant.
(Get 15% Discount on Buying this Report)
A full report of Global Peri-implantitis Market is available at: https://orionmarketreports.com/peri-implantitis-market/84099/
Market Segments
By Method Type
- Surgical Treatment
- Mechanical Debridement
- Laser Debridement
- Open Flap Debridement
- Open Flap Debridement with guided bone generation.
- Non Surgical Treatment
- Surface Debridement
- Antibiotics ( Chlorhexidine Digluconate )
Key Players
- Pfizer Inc.
- Cadila Pharmaceuticals
- R.N. Laboratories Pvt. Ltd.
- Basic Pharma Life Science Pvt. Ltd.
- Prachi Pharmaceuticals Private Limited.
- Geistlich Pharma Inc.
- Healthy Life Pharma.
Scope of the Report
The research study analyzes the global Peri-implantitis industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent Developments
o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment
Geographic Coverage
o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume
Key Questions Answered by Peri-implantitis Market Report
1. What was the Peri-implantitis Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).
2. What will be the CAGR of Peri-implantitis Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Peri-implantitis Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
The report covers the following objectives:
- Proliferation and maturation of trade in the global Peri-implantitis market.
- The market share of the global Peri-implantitis market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the global Peri-implantitis market.
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Peri-implantitis market.
About Us:
Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
